Joshi N, Chaturvedi S, Coplin W M
WSU/DMC Stroke Program and Department of Neurology, Wayne State University/Detroit Medical Center, 8C-UHC, 4201 St. Antoine, Detroit, MI 48201, USA.
J Neuroimaging. 2001 Jan;11(1):40-3. doi: 10.1111/j.1552-6569.2001.tb00007.x.
Whether acute stroke patients with major early infarct signs on computed tomography (CT) should be treated with intravenous (i.v.) thrombolysis remains controversial. The authors sought to define the outcomes in 5 consecutive patients who were not treated with i.v. thrombolysis, according to established guidelines.
The authors retrospectively analyzed the outcomes of a consecutive series of 5 patients evaluated by an acute stroke team at a university medical center and who were denied i.v. tissue plasminogen activator due to early CT changes.
Five patients with a median National Institutes of Health Stroke Scale score of 22 (range 20-28) were evaluated. Despite aggressive care (e.g., hemicraniectomy), 2 patients died owing to herniation, 1 patient died of cardiac causes, and neither of the 2 surviving patients achieved a 3-month Rankin score below 4 (moderately severe disability).
Given the poor prognosis of patients with hemispheric stroke and early CT changes, alternative treatment modalities such as intra-arterial thrombolysis, early hemicraniectomy, and neuroprotective therapy should be vigorously pursued.
对于计算机断层扫描(CT)显示有早期大面积梗死征象的急性中风患者,是否应采用静脉内(i.v.)溶栓治疗仍存在争议。作者试图根据既定指南确定5例未接受静脉溶栓治疗患者的治疗结果。
作者回顾性分析了一所大学医学中心急性中风团队评估的连续5例患者的治疗结果,这些患者因早期CT改变而未接受静脉注射组织纤溶酶原激活剂治疗。
评估了5例患者,美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale)评分中位数为22(范围20 - 28)。尽管采取了积极治疗(如去骨瓣减压术),2例患者因脑疝死亡,1例患者死于心脏原因,2例存活患者在3个月时的改良Rankin量表评分均未低于4分(中度严重残疾)。
鉴于半球性中风且有早期CT改变患者的预后较差,应大力探索替代治疗方式,如动脉内溶栓、早期去骨瓣减压术和神经保护治疗。